Anti-Tumor Effect of Autologous Cytokine-Induced Killer (CIK) Cells in Patients With Advanced Primary Hepotic Carcinoma

Cytokine-induced killer (CIK) cells therapy has been evaluated as an effective treatment for patients with malignant tumors. In this study, we aimed to assess the efficacy of CIK cell-based therapy compared with traditional treatment in patients with advanced primary hepatic carcinoma (PHC).